Fundz

Bio Phy reported raising $6.61 Million in an initial SEC Form D filing, from an offering of $6.61 Million

PRIVATEMar 20, 2025

Amount Raised

$6.61 Million

$6.61 Million sold, per SEC Form D (first sale Mar 4, 2025)

Round Type

Venture

PhiladelphiaBiotechnologyArtificial IntelligencePharmaceutical

Quick answer

BioPhy raised $6.61 Million in a funding round, dated March 4, 2025. BioPhy is based in Philadelphia, Pennsylvania, United States.

How much did BioPhy raise?
BioPhy raised $6.61 Million in a funding round on March 4, 2025.
What does BioPhy do?
BioPhy is leveraging modern science and advanced technologies to transform the way promising drugs are identified, developed, and tested.
Where is BioPhy based and how big is it?
BioPhy is based in Philadelphia, Pennsylvania, United States. Fundz records about 14 employees.
Who are the decision-makers at BioPhy?
Fundz holds 2 contacts at BioPhy. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Biotechnology around the same time

Companies in the same sectors as BioPhy that raised within 45 days of this round, from Fundz verified event records.

  • Pathos AI raised $283M on April 17, 2025.
  • QurieGen raised $2.4M (Pre-Seed) on April 8, 2025.
  • Phenaros Pharmaceuticals raised an undisclosed amount (Pre-Seed) on January 30, 2025.
  • RISA Labs raised $3.5M (Seed) on April 17, 2025.
  • Skin Analytics raised $20M (Series B) on April 16, 2025.
  • Safe Superintelligence raised $2B (Funding Round) on April 14, 2025.

Who to call at BioPhy, and when

A new round usually means BioPhy is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioPhy raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioPhy, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioPhy. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioPhy

Location

Philadelphia, Pennsylvania, United States

About

BioPhy is leveraging modern science and advanced technologies to transform the way promising drugs are identified, developed, and tested. With its patent-pending predictive AI engine, BioLogic, and generative AI solution, BioPhyRx, the company enhances clinical trial outcomes, reduces failure and non-compliance rates, accelerates drug development, and improves healthcare outcomes worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioPhy raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for BioPhy's next move

See what Strategic adds

BioPhy raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.